Sentences with phrase «price than a growth stock»

Due to this fundamental distinction, a value stock is often traded at a more affordable price than a growth stock.

Not exact matches

That's massive growth, no matter how you look at it, which helped push the stock price (NFLX) up by more than 139 % last year.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

But anyone hoping for the kind of stock growth Shoppers enjoyed over the past decade — when its share price climbed from less than $ 18 to, at one point, over $ 55 — will be disappointed.

At this point then yes price appreciation is secondary bonus and we have an arguement of how and why Real Estate can be better than Growth Stocks in some scenarios and for some investors.

World growth will remain low on average but negative in the UK and Europe; price inflation will remain sufficiently subdued for a while longer so as to impose no constraint on monetary expansion; central banks will sustain a regime of negative real interest rates and rapid monetary expansion; the risk of a eurozone collapse is off the table for now; finally, stock markets should continue to perform better than expected, even though the four - year old cyclical bull market is long by historical standards.

The r - squared value of 0.0006 in Figure 1 shows that EPS growth over the past five years explains less than one tenth of one percent of the difference in price between stocks in the S&P 500.

With better - than - reported fundamentals, a long history of dividend growth, and undervalued stock price, this firm earns a spot on this month's Dividend Growth Stocks Model Portfolio and is this week's Longgrowth, and undervalued stock price, this firm earns a spot on this month's Dividend Growth Stocks Model Portfolio and is this week's LongGrowth Stocks Model Portfolio and is this week's Long Idea.

And no matter where the market is trading, «faster - than - expected earnings growth is often taken as a sign that stock prices should be higher — which often becomes a self - fulfilling prophecy.»

That's because there's a margin of safety, or a buffer, that's often built right in when you buy a dividend growth stock that's undervalued, as that favorable gap between price and value also means there's less of a possibility that the stock becomes worth less than you paid through some kind of negative event (corporate malfeasance, investor mistake, etc.).

In recent years, U.S. equities overall have generally seen their stock prices gain from multiple expansion, rather than significant earnings growth.

On the other hand, stock prices are — to a certain extent — a function of earnings growth, and smaller companies are often able to increase their profits at a faster speed than larger businesses.

A stock's PEG ratio — its price - to - earnings ratio divided by the growth rate of its earnings — often is considered a more complete assessment of a company's current valuation than a P / E ratio because it takes earnings growth into account.

The Fund invests in growth stocks, which may be more sensitive to market movements because their prices tend to reflect future investor expectations rather than just current profits.

Asian stock markets fell Thursday as weaker - than - expected orders for U.S. durable goods, falling commodities prices and signs of slower economic growth in Britain kept investors at bay.

Unlike more defensive sectors (such as utilities), price gains for mature tech stocks have largely been led by earnings growth rather than by multiples expansion.

A key indicator of a strong stock, they believe, is an earnings growth rate that is greater than the stock's price / earnings ratio.

As you know as well as I do, the beginning and growth stages there is not much give back to shareholders other than in the form of stock price increases which are not guaranteed.

With a price - to - earnings ratio of 17 (lower than its already conservative price - to - earnings ratio of 18.5 earlier this week) and trailing -12-month year - over-year sales and earnings growth of 10 % and 22 %, respectively, a pullback could represent a time to consider buying Apple stock.

Because of their high prices and low yields, growth stocks tend to have less downside protection and more volatility than cheaper companies.

Shell Oil has more excess profit at its disposal to fund future dividend growth than AT&T does (although AT&T is a non-cyclical stock that can rely upon steady cash flow from which to pay shareholders each year, whereas Royal Dutch Shell is an oil company that experiences low profits for 2 - 3 out of every ten due to the cyclical nature of oil and natural gas prices).

The eighth sure thing was that, with non-U.S. developed market and emerging market economies generally growing at a slower pace than the U.S. economy (and with many emerging markets hurt by weak commodity prices, slower growth in China's economy, the Fed tightening monetary policy and a rising dollar), international developed market stocks would underperform U.S. stocks in 2017.

Based on the year - end 2016 price for the growth share being 10 % below average (63 % vs 70 %), this model suggests that stocks presently could be more attractive than usual.

Buying stocks with a price less than or equal to two - thirds of the tangible book value would have generated an average compounded growth rate of 14.2 %.

When the economy is expanding, earnings tend to grow across the market and in such an environment, investors historically could purchase value cyclical stocks at a much more attractive price than evergreen growth stocks.

One would want to pick out those high - quality dividend growth stocks that are priced less than they're actually worth for three massive reasons:

One, the prices of dividend stocks tend to be less volatile over time than non-dividend payers or «growth» stocks.

But with global growth still sluggish and bond and stock prices looking expensive, balancing income and risk is more important (and challenging) than ever.

Our superb investment results in General Growth Properties, where the stock price had declined more than 99 % before we made our first purchase, gave us confidence that we could assist Valeant in a turnaround after its stock price collapse.

It is reasonably priced and better than average prospects for continued growth and returns to stock holders.

In the long run, value stocks have generated higher returns than growth stocks, which have higher stock prices and earnings, albeit because value stocks have higher risk.

More than share market sentiment, a fundamentally good stock's business ambience and business growth determine its share price in the long run..

Rather, than relying on resource conversions to achieve appreciation in common stock prices, TAM relies basically on long term growth in NAVs.

A surprisingly large part of the overall growth in most portfolios comes from reinvested dividends rather than in appreciation of the stock prices.

They have low price - to - earnings and price - to - book ratios — which is why they're less expensive than growth stocks.

They have a low price - to - earnings and price - to - book ratios — which is why they're less expensive than growth stocks.

Seeks to invest in high - quality growth stocks that are attractively priced and growing their near ‐ term earnings faster than the market

When choosing the appropriate dividend growth stock, many dividend growth investors will rightfully focus on the company's dividend record and dividend growth more than they will its price history.

It is well known that low price - to - earnings (P / E) stocks, or value stocks, on average, earn higher returns than high P / E stocks, or growth stocks.

The strength of dividend growth investing is that it puts investor focus on growing dividend payments rather than fluctuating stock prices.

A PEG of less than 1 implies that, at present, the stock's price is lower than it should be given its earnings growth.

But this, my friends, amounts to nothing more than a red herring... A true growth stock always seems to be over-valued, yet its share price can subsequently look astonishingly & ridiculously cheap after the business / stock somehow manages to scale up by hundreds or even thousands of percent.

These are high - quality dividend growth stocks that appear to be undervalued (priced less than intrinsic value) at the time of publication.

Grainger (GWW) has seen its stock price slide by more than 20 % since early February, catching the attention of many value - focused dividend growth investors.

Shell Oil has more excess profit at its disposal to fund future dividend growth than AT&T does (although AT&T is a non-cyclical stock that can rely upon steady cash flow from which to pay shareholders each year, whereas Royal Dutch Shell is an oil company that experiences low profits for 2 - 3 out of every ten due to the cyclical nature of oil and natural gas prices).

Gyrating stock values, slumping oil prices, turmoil in foreign currency markets, predictions of slow growth or even deflation abroad... Suddenly, the outlook for the global economy and financial markets looks far different — and much dicier — than just a few months ago.

Remember, if we know the price - to - free - cash - flow multiple is going to contract at some point, then we know free cash flow has to grow faster than market cap — and you are only going to make money (unless the company buys back stock or pays a dividend) from market cap growth.

As you might have thought the growth companies would do well, you would no longer talk about a premium for growth companies once you discover that it's a value company, once that has lower growth prospects and sell at low prices rather than high stock prices, which have provided a reward.

However, since all three screens look for stocks with strong recent price action, it is not surprising that the median price - earnings ratios for the Bargain screen (37.0) and Growth screen (108.0) are significantly higher than the median price - earnings ratio for exchange - listed stocks (18.1).

Because the markets are forward looking, maybe they're predicting more growth than before, and so stock prices could be very fair today.